Back to News
Market Impact: 0.2
PathMaker Neurosystems Announces Publication of First-Ever Study Showing Non-Invasive Clearance of Toxic TDP-43 Protein Aggregates in Preclinical ALS Study
Source: GlobeNewswire
Healthcare & BiotechTechnology & Innovation
PathMaker Neurosystems announced its first study showing that its non-invasive Multi-Site DCS technology can reduce toxic TDP-43 protein in ALS motor neurons. The article provides no study size, effect magnitude, or clinical outcome data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Singapore's Temasek warns of the ‘biggest risk’ facing markets right now
- A 32% beat, a +6% jump: the IT solutions name our models picked in July
- What Marvell's rosy long-term guidance means for our AI chip stocks
- Meta may ditch the idea of a cloud business for Muse. We think that’s a good trade
- Malaysia 2027 budget to tackle living costs, fiscal risks as election looms
- Google teams with nuclear power giant to give reactors a tune-up